First Time Loading...

BRAIN Biotech AG
XETRA:BNN

Watchlist Manager
BRAIN Biotech AG Logo
BRAIN Biotech AG
XETRA:BNN
Watchlist
Price: 2.81 EUR -1.75% Market Closed
Updated: Apr 23, 2024

ROA
Return on Assets

-11.8%
Current
-10%
Average
2.9%
Industry
Negative for the last year
-11.8%
Negative average
-10%
Worse than average
Worse than industry value

ROA, or Return on Assets, is an indicator of how well a company utilizes its assets in terms of profitability. This number tells you what the company can do with what it has, i.e. how many dollars of earnings they derive from each dollar of assets they control. A higher ROA indicates more efficient use of assets to produce earnings, making it a valuable gauge for investors assessing a company's operational efficiency and profitability potential.

ROA
-11.8%
=
Net Income
-8.4m
/
Total Assets
70.5m

ROA Across Competitors

ROA Comparison
BRAIN Biotech AG Competitors

Country DE
Market Cap 61.4m EUR
ROA
-12%
Country JP
Market Cap 12.4T JPY
ROA
11%
Country US
Market Cap 77.1B USD
ROA
10%
Country US
Market Cap 62.9B USD
ROA
6%
Country CH
Market Cap 41.5B CHF
ROA
8%
Country CH
Market Cap 36.6B CHF
ROA
8%
Country CN
Market Cap 265.3B CNY
ROA
7%
Country IN
Market Cap 2.8T INR
ROA
21%
Country US
Market Cap 31.7B USD
ROA
1%
Country US
Market Cap 30.7B USD
ROA
6%
Country CH
Market Cap 28.2B EUR
ROA
8%

Profitability Report

View the profitability report to see the full profitability analysis for BRAIN Biotech AG.

See Also

Discover More
What is Return on Assets?

ROA, or Return on Assets, is an indicator of how well a company utilizes its assets in terms of profitability. This number tells you what the company can do with what it has, i.e. how many dollars of earnings they derive from each dollar of assets they control. A higher ROA indicates more efficient use of assets to produce earnings, making it a valuable gauge for investors assessing a company's operational efficiency and profitability potential.

ROA
-11.8%
=
Net Income
-8.4m
/
Total Assets
70.5m
What is the ROA of BRAIN Biotech AG?

Based on BRAIN Biotech AG's most recent financial statements, the company has ROA of -11.8%.